oxazoles has been researched along with Tuberculosis, Pulmonary in 34 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 8 (23.53) | 18.7374 |
1990's | 1 (2.94) | 18.2507 |
2000's | 4 (11.76) | 29.6817 |
2010's | 16 (47.06) | 24.3611 |
2020's | 5 (14.71) | 2.80 |
Authors | Studies |
---|---|
Bin, W; Chen, S; Ding, CZ; Franzblau, SG; Hu, Y; Huang, Z; Jiang, N; Luo, W; Shen, L; Tao, X; Wei, X; Wei, Y; Xu, D; Yang, M; Zhu, Y | 1 |
Kudoh, S; Kurashima, A; Ogata, H; Ohta, K; Okumura, M; Yoshimori, K; Yoshiyama, T | 1 |
Jeon, D; Jo, KW; Kang, H; Shim, TS; Yim, JJ | 1 |
Gibiansky, E; Mallikaarjun, S; Wang, X | 1 |
Chopra, V; Gupta, A | 1 |
Akkerman, O; Alffenaar, JW; Amale, R; Centis, R; D'Ambrosio, L; Ganatra, S; Maryandyshev, A; Migliori, GB; Mullerpattan, J; Pontali, E; Sadutshang, TD; Sotgiu, G; Tiberi, S; Topgyal, S; Udwadia, ZF | 1 |
Dowdy, D; Merritt, MW; Taylor, H; von Delft, A; Zwerling, A | 1 |
Centis, R; D'Ambrosio, L; Migliori, GB; Pontali, E; Spanevello, A; Visca, D | 1 |
Ade, S; Alikhanova, N; Benedetti, G; Cox, H; Daniels, J; De Azevedo, V; Edwards, J; Ferlazzo, G; Furin, J; Hughes, J; Isaakidis, P; Kock, Y; Mohr, E; Reuter, A; Shroufi, A; Steele, SJ; Trivino Duran, L | 1 |
Balanag, V; Bielskiene, V; Cadena, E; Caoili, J; Cirule, A; Danilovits, M; Davidaviciene, E; Domente, L; Geiter, LJ; Gupta, R; Hafkin, J; Hittel, N; Lizarbe, V; Patientia, R; Petersen, C; Sanchez, E; Segura, P; Staples, S; Ticona, E; Variava, E; von Groote-Bidlingmaier, F; Wells, C; Yu, C | 1 |
Ahn, H; Ahn, JH; Cho, SN; Hahn, S; Jang, JY; Jeon, D; Jhun, BW; Jo, KW; Kang, YA; Kim, CK; Kim, DK; Kim, JS; Kim, SY; Kim, YR; Koh, WJ; Lee, JH; Lee, JY; Lee, M; Lee, SH; Lee, T; Mok, J; Park, JS; Shim, TS; Shin, S; Shin, SJ; Song, T; Won, HJ; Yim, JJ | 1 |
Arora, VK; Chopra, KK | 1 |
Jeong, BH; Koh, WJ; Kwon, YS | 1 |
Lynch, JB; Szumowski, JD | 1 |
Bianchini, S; Blasi, F; Esposito, S | 1 |
Betoudji, F; Converse, PJ; Dartois, V; Li, SY; Mdluli, KE; Mendel, CM; Nuermberger, EL; Tasneen, R; Tyagi, S; Williams, K; Yang, T | 1 |
Dawson, A; Silva, DS; Upshur, RE | 1 |
Fujiwara, M; Geiter, L; Kawasaki, M; Kreiswirth, BN; Kurepina, N; Liu, Y; Matsumoto, M; Shashkina, E; Stinson, K; Timm, J; Venter, A | 1 |
Dass, R; Hettle, R; Wirth, D | 1 |
Mancera, RL; Rivers, EC | 1 |
Dawson, R; Diacon, AH; Donald, PR; Geiter, LJ; Hanekom, M; Hittel, N; Narunsky, K; Paccaly, AJ; Venter, A; Wells, CD | 1 |
Bandermann, S; Hahnke, K; Kahnert, A; Kaufmann, SH; Mollenkopf, H; Seiler, P; Stein, M | 1 |
Zhang, Y | 1 |
Kobayashi, K; Okada, M | 1 |
Ashtekar, DR; Bhatt, AD; Costa-Perira, R; Nagrajan, K; Rittel, W; Vishvanathan, N | 1 |
Papezhova, E; Toushek, I | 1 |
Kheifets, LB; Kozlova, NE | 1 |
Kolosovskaia, VP; Shabalova, LN; Shmelev, NA | 1 |
Kolosovskaia, VP; Korotaev, GA | 1 |
Böszörményi, M | 1 |
Aimone, J; Dumon, G; Dumon, JF | 1 |
Tousek, J; Zítková, L | 1 |
Antunes, G; Gomes, A; Rizzo, A | 1 |
7 review(s) available for oxazoles and Tuberculosis, Pulmonary
Article | Year |
---|---|
Evolution of newer regimens in TB from RNTCP to NTEP.
Topics: Antitubercular Agents; Diarylquinolines; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Nitroimidazoles; Oxazoles; Tuberculosis, Pulmonary | 2020 |
Multi and extensively drug-resistant pulmonary tuberculosis: advances in diagnosis and management.
Topics: Adolescent; Antitubercular Agents; Child; Diarylquinolines; Drug Therapy, Combination; Extensively Drug-Resistant Tuberculosis; Humans; Nitroimidazoles; Oxazoles; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2018 |
Delamanid when other anti-tuberculosis-treatment regimens failed due to resistance or tolerability.
Topics: Antitubercular Agents; Clinical Trials as Topic; Drug Resistance, Bacterial; Drug Therapy, Combination; Humans; Mycobacterium tuberculosis; Nitroimidazoles; Oxazoles; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2015 |
Profile of delamanid for the treatment of multidrug-resistant tuberculosis.
Topics: Animals; Antitubercular Agents; Drug Interactions; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Humans; Long QT Syndrome; Mycobacterium tuberculosis; Nitroimidazoles; Oxazoles; Risk Assessment; Risk Factors; Sputum; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2015 |
Bedaquiline and delamanid in tuberculosis.
Topics: Antitubercular Agents; Clinical Trials as Topic; Diarylquinolines; Drug Interactions; Drug Resistance, Bacterial; Humans; Nitroimidazoles; Oxazoles; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2015 |
New anti-tuberculosis drugs with novel mechanisms of action.
Topics: Adamantane; Animals; Antitubercular Agents; Diarylquinolines; Drug Design; Drug Resistance, Multiple, Bacterial; Ethylenediamines; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nitroimidazoles; Oxazoles; Quinolines; Structure-Activity Relationship; Tuberculosis, Pulmonary | 2008 |
Advances in the treatment of tuberculosis.
Topics: Adamantane; AIDS-Related Opportunistic Infections; Animals; Anti-Bacterial Agents; Antitubercular Agents; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Drugs, Investigational; Ethylenediamines; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; Humans; Isoniazid; Mycobacterium tuberculosis; Nitroimidazoles; Oxazoles; Pyrazinamide; Rifampin; Treatment Refusal; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2007 |
6 trial(s) available for oxazoles and Tuberculosis, Pulmonary
Article | Year |
---|---|
Efficacy and safety of delamanid in combination with an optimised background regimen for treatment of multidrug-resistant tuberculosis: a multicentre, randomised, double-blind, placebo-controlled, parallel group phase 3 trial.
Topics: Antitubercular Agents; Double-Blind Method; Drug Administration Schedule; Drug Monitoring; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Middle Aged; Nitroimidazoles; Oxazoles; Rifampin; Sputum; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2019 |
Delamanid, linezolid, levofloxacin, and pyrazinamide for the treatment of patients with fluoroquinolone-sensitive multidrug-resistant tuberculosis (Treatment Shortening of MDR-TB Using Existing and New Drugs, MDR-END): study protocol for a phase II/III, m
Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Equivalence Trials as Topic; Female; Humans; Levofloxacin; Linezolid; Male; Middle Aged; Multicenter Studies as Topic; Mycobacterium tuberculosis; Nitroimidazoles; Oxazoles; Pyrazinamide; Republic of Korea; Time Factors; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult | 2019 |
MIC of Delamanid (OPC-67683) against Mycobacterium tuberculosis Clinical Isolates and a Proposed Critical Concentration.
Topics: Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nitroimidazoles; Oxazoles; Tuberculosis, Pulmonary | 2016 |
Early bactericidal activity of delamanid (OPC-67683) in smear-positive pulmonary tuberculosis patients.
Topics: Adolescent; Adult; Antitubercular Agents; Colony Count, Microbial; Dose-Response Relationship, Drug; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Nitroimidazoles; Oxazoles; Sputum; Treatment Outcome; Tuberculosis, Pulmonary; Young Adult | 2011 |
[Comparative clinical electroencephalographic study of cycloserine and terizidon tolerance].
Topics: Adolescent; Adult; Antitubercular Agents; Central Nervous System; Chronic Disease; Clinical Trials as Topic; Cycloserine; Drug Tolerance; Electroencephalography; Humans; Imines; Male; Middle Aged; Oxazoles; Tuberculosis, Pulmonary | 1975 |
[Triple placebo test for comparison of side effects of terizidone (terivalidin) and cycloserine].
Topics: Clinical Trials as Topic; Cycloserine; Female; Humans; Imines; Male; Mental Disorders; Oxazoles; Seizures; Sleep Initiation and Maintenance Disorders; Tremor; Tuberculosis, Pulmonary; Vertigo | 1973 |
21 other study(ies) available for oxazoles and Tuberculosis, Pulmonary
Article | Year |
---|---|
Discovery and preclinical evaluations of JBD0131, a novel nitrodihydro-imidazooxazole anti-tuberculosis agent.
Topics: Antitubercular Agents; Humans; Mycobacterium tuberculosis; Nitroimidazoles; Oxazoles; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2022 |
Treatment of multidrug-resistant pulmonary tuberculosis with delamanid based on Japanese guideline recommendations.
Topics: Adult; Antitubercular Agents; Drug Resistance, Multiple; Female; Humans; Japan; Male; Middle Aged; Nitroimidazoles; Oxazoles; Practice Guidelines as Topic; Tuberculosis, Pulmonary | 2020 |
Interim treatment outcomes in multidrug-resistant tuberculosis using bedaquiline and/or delamanid in South Korea.
Topics: Age Factors; Aged; Body Mass Index; Diarylquinolines; Drug Resistance, Bacterial; Drug Resistance, Multiple; Drug Therapy, Combination; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Nitroimidazoles; Oxazoles; Republic of Korea; Retrospective Studies; Risk Factors; Safety; Time Factors; Treatment Outcome; Tuberculosis, Pulmonary | 2020 |
Population Pharmacokinetic Analysis of Delamanid in Patients with Pulmonary Multidrug-Resistant Tuberculosis.
Topics: Adolescent; Adult; Antitubercular Agents; Humans; Middle Aged; Nitroimidazoles; Oxazoles; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult | 2020 |
Bedaquiline and Delamanid Combination Treatment of 5 Patients with Pulmonary Extensively Drug-Resistant Tuberculosis.
Topics: Adolescent; Adult; Antitubercular Agents; Diarylquinolines; Drug Therapy, Combination; Extensively Drug-Resistant Tuberculosis; Female; Humans; Male; Nitroimidazoles; Oxazoles; Tuberculosis, Pulmonary; Young Adult | 2017 |
Incorporating social justice and stigma in cost-effectiveness analysis: drug-resistant tuberculosis treatment.
Topics: Antitubercular Agents; Cost-Benefit Analysis; Decision Trees; Diarylquinolines; Humans; Models, Theoretical; Nitroimidazoles; Oxazoles; Social Justice; Social Stigma; South Africa; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2017 |
Delamanid for rifampicin-resistant tuberculosis: a retrospective study from South Africa.
Topics: Adult; Antitubercular Agents; Female; Humans; Logistic Models; Male; Nitroimidazoles; Oxazoles; Retrospective Studies; Rifampin; South Africa; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2018 |
Delamanid (Deltyba°) and multidrug-resistant pulmonary tuberculosis.
Topics: Antitubercular Agents; Electrocardiography; Humans; Long QT Syndrome; Nitroimidazoles; Oxazoles; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2017 |
Journey of tuberculosis control in India.
Topics: Antitubercular Agents; Diarylquinolines; Directly Observed Therapy; Goals; History, 20th Century; History, 21st Century; Humans; India; National Health Programs; Nitroimidazoles; Oxazoles; Practice Guidelines as Topic; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2019 |
Contribution of Oxazolidinones to the Efficacy of Novel Regimens Containing Bedaquiline and Pretomanid in a Mouse Model of Tuberculosis.
Topics: Animals; Antitubercular Agents; Bacterial Load; Diarylquinolines; Disease Models, Animal; Drug Administration Schedule; Drug Combinations; Drug Resistance, Multiple, Bacterial; Drug Synergism; Female; Linezolid; Lung; Mice; Mice, Inbred BALB C; Mycobacterium tuberculosis; Nitroimidazoles; Organophosphates; Oxazoles; Oxazolidinones; Pyrazinamide; Time Factors; Treatment Outcome; Tuberculosis, Pulmonary | 2016 |
Reciprocity and Ethical Tuberculosis Treatment and Control.
Topics: Antitubercular Agents; Beneficence; Communicable Disease Control; Congresses as Topic; Diarylquinolines; Directly Observed Therapy; Ethical Analysis; Ethical Theory; Global Health; Humans; Moral Obligations; Nitroimidazoles; Oxazoles; Patient Isolation; Personal Autonomy; Pharmacovigilance; Poverty; Public Health; Social Justice; Social Responsibility; Tuberculosis, Laryngeal; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Virtues | 2016 |
Cost-effectiveness of adding novel or group 5 interventions to a background regimen for the treatment of multidrug-resistant tuberculosis in Germany.
Topics: Adult; Antitubercular Agents; Clinical Protocols; Clinical Trials as Topic; Cost-Benefit Analysis; Diarylquinolines; Drug Costs; Drug Therapy, Combination; Female; Germany; Humans; Linezolid; Male; Nitroimidazoles; Observational Studies as Topic; Oxazoles; Quality-Adjusted Life Years; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2017 |
Alternative activation deprives macrophages of a coordinated defense program to Mycobacterium tuberculosis.
Topics: Animals; Antineoplastic Agents; Bacterial Proteins; Bone Marrow Cells; Gene Expression Regulation; Gene Expression Regulation, Bacterial; Helminthiasis; Interferon-gamma; Interleukin-4; Iron; Lung; Macrophage Activation; Macrophages; Matrix Metalloproteinase 12; Metalloendopeptidases; Mice; Mycobacterium tuberculosis; Oxazoles; Th1 Cells; Th2 Cells; Tuberculosis, Pulmonary | 2006 |
[Recent progress in mycobacteriology].
Topics: Animals; Antitubercular Agents; Bacterial Proteins; Bacteriology; DNA-Binding Proteins; Drug Design; Humans; Immunoenzyme Techniques; Japan; Mice; Minisatellite Repeats; Molecular Epidemiology; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Mycobacterium tuberculosis; Nitroimidazoles; Oxazoles; Serologic Tests; Tuberculosis Vaccines; Tuberculosis, Pulmonary | 2007 |
In vitro and in vivo activities of the nitroimidazole CGI 17341 against Mycobacterium tuberculosis.
Topics: Animals; Antitubercular Agents; Bacteroides fragilis; Culture Media; Drug Resistance, Microbial; Female; Hydrogen-Ion Concentration; Mice; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nitroimidazoles; Oxazoles; Tuberculosis, Pulmonary | 1993 |
[Remote results of chemotherapy in tuberculosis].
Topics: Czechoslovakia; Ethambutol; Humans; Oxazoles; Phenylthiourea; Prothionamide; Rifampin; Thiosemicarbazones; Tuberculosis, Pulmonary | 1977 |
[Effect of cycloserine and terizidon on intracellular reproduction of mycobacterium tuberculosis].
Topics: Animals; Antitubercular Agents; Culture Techniques; Cycloserine; Evaluation Studies as Topic; Guinea Pigs; Macrophages; Mycobacterium tuberculosis; Oxazoles; Tuberculosis, Pulmonary | 1975 |
[Terisidon in chemotherapy of pulmonary tuberculosis].
Topics: Adult; Antitubercular Agents; Cycloserine; Drug Evaluation; Drug Tolerance; Female; Humans; Imines; Male; Oxazoles; Tuberculosis, Pulmonary | 1974 |
[Preliminary note on Terizidone].
Topics: Adult; Antitubercular Agents; Female; Humans; Imines; Male; Middle Aged; Oxazoles; Tuberculosis, Pulmonary | 1972 |
Pharmacokinetics of cycloserine and terizidone. A comparative study.
Topics: Adolescent; Adult; Aged; Aldehydes; Cycloserine; Dose-Response Relationship, Drug; Half-Life; Humans; Imines; Kinetics; Male; Middle Aged; Oxazoles; Phthalic Acids; Schiff Bases; Time Factors; Tuberculosis, Pulmonary | 1974 |
[Cycloserine and terizidone in the treatment of pulmonary tuberculosis: clinical study of tolerance].
Topics: Cycloserine; Drug Tolerance; Female; Humans; Male; Oxazoles; Tuberculosis, Pulmonary | 1969 |